logo
  Join        Login             Stock Quote

Healthcare Poised For Growth Under Obamacare

 January 02, 2013 10:10 AM
 


(By Robert Freedland) 2012 was a very good year for the Covestor Healthcare model that I manage. I attribute the strong performance to the healthcare sector, which turned out to be a good area for the average investor.

With the Affordable Care Act ("Obamacare") continuing to roll out into 2013, I believe that the added patient volume that should come along with the expanded coverage will bring opportunity as well as stress to the healthcare community.

Companies that help reduce costs and improve efficiencies for healthcare delivery should benefit. These companies include stocks involved in providing less expensive drugs whether by utilizing generics including drugs produced by Mylan (MYL), a significant holding in the model, or by cost-effective delivery by a company like Express Scripts (ESRX) a stock that I have owned in the past but do not currently hold.

[Related -Express Scripts Holding Company (ESRX): Should You Own ESRX in 2014?]

The future remains bright for biotech companies that are producing real products treating real diseases.  These include Healthcare Model holdings Amgen (AMGN), Celgene (CELG), and Regeneron (REGN).

[Related -Amgen, Inc. (NASDAQ:AMGN): What Will Drive Amgen This Year?]

The added patient volume associated with healthcare reform will contribute to revenue growth at established large pharmaceutical and healthcare supply companies like Johnson & Johnson (JNJ), Novo Nordisk (NVO) and Baxter (BAX), all three are holdings of the Healthcare Model.

One area that I have included in the Model involves healthcare for animals with MWI Veterinary (MWIV). This company delivers supplies to Veterinarians and is growing quickly and should have potential to continue to grow into 2013.

In my opinion, this sector will continue to be strong into 2013. I will continue to 'ride herd' over this group of stocks and be quick to exit any holding with any fundamental negative announcement or actual technical price weakness that might suggest price decline into the future. However, I shall work to be patient with those holdings that are doing well and continue to look for new possibilities and ideas for inclusion into the New Year.

Certain information contained in this presentation is based upon forward-looking statements, information and opinions, including descriptions of anticipated market changes and expectations of future activity. The manager believes that such statements, information and opinions are based upon reasonable estimates and assumptions. However, forward-looking statements, information and opinions are inherently uncertain and actual events or results may differ materially from those reflected in the forward-looking statements. Therefore, undue reliance should not be placed on such forward-looking statements, information and opinions.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageLadenburg Thalmann Financial Services (NYSEMKT:LTS): Heavy, Durable Insider Buying

Ahh, but any worries over price levels didn’t stop multiple insiders at Ladenburg Thalmann Financial read on...

article imageInternational Business Machines Corp. (IBM) Q2 Earnings Preview: Small Beat and Pop

International Business Machines Corp. (NYSE:IBM) will host a conference call Wednesday, Jul. 16, 2014 at read on...

article imageGoogle Inc. (GOOGL) Q2 Earnings Preview: A Few Pennies Either Way Make a Big Difference.

Google Inc. (NASDAQ:GOOGL) will hold its quarterly conference call to discuss second quarter 2014 financial read on...

article image19 Companies That Could Beat Earnings and Pop on Price Next Week

Using iStock’s proprietary iEstimates model, we have identified 19 publicly traded companies that could read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.